APA (7th ed.) Citation

Muley, T., Dienemann, H., Herth, F., Thomas, M., Meister, M., & Schneider, J. (2013). Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer. Journal of thoracic oncology, 8(7), . https://doi.org/10.1097/JTO.0b013e31828f696b

Chicago Style (17th ed.) Citation

Muley, Thomas, Hendrik Dienemann, Felix Herth, Michael Thomas, Michael Meister, and Joachim Schneider. "Combination of Mesothelin and CEA Significantly Improves the Differentiation Between Malignant Pleural Mesothelioma, Benign Asbestos Disease, and Lung Cancer." Journal of Thoracic Oncology 8, no. 7 (2013). https://doi.org/10.1097/JTO.0b013e31828f696b.

MLA (9th ed.) Citation

Muley, Thomas, et al. "Combination of Mesothelin and CEA Significantly Improves the Differentiation Between Malignant Pleural Mesothelioma, Benign Asbestos Disease, and Lung Cancer." Journal of Thoracic Oncology, vol. 8, no. 7, 2013, https://doi.org/10.1097/JTO.0b013e31828f696b.